Published in Arch Dermatol on October 01, 1988
Shampoo and Conditioners: What a Dermatologist Should Know? Indian J Dermatol (2015) 1.08
Moisturizer allergy: diagnosis and management. J Clin Aesthet Dermatol (2008) 0.90
Patch testing in suspected allergic contact dermatitis to cosmetics. Dermatol Res Pract (2014) 0.79
Comparison of Marketed Cosmetic Products Constituents with the Antigens Included in Cosmetic-related Patch Test. Ann Dermatol (2010) 0.78
A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin Reactions. Antioxidants (Basel) (2015) 0.75
Evaluation of the cytotoxicity and phototoxicity of Caryocar brasiliense supercritical carbon dioxide extract. BMC Complement Altern Med (2014) 0.75
Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol (1990) 3.77
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol (1998) 3.38
Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol (1993) 2.63
Evaluation of an enzyme immunoassay for the diagnosis of chlamydial infections in urogenital specimens. J Clin Microbiol (1986) 2.44
Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol (1998) 2.30
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29
Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. J Am Acad Dermatol (1995) 2.14
Expression of E-cadherin, alpha- & beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma. Hum Pathol (1999) 2.06
Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J Am Acad Dermatol (1999) 2.03
Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today (1991) 1.89
The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. Arch Dermatol (1999) 1.73
Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol (2010) 1.68
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol (2001) 1.65
Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000). Contact Dermatitis (2002) 1.63
Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. J Invest Dermatol (1990) 1.62
Human atopen-specific types 1 and 2 T helper cell clones. J Immunol (1991) 1.62
Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol (1990) 1.59
Survival of Chlamydia trachomatis in different transport media and at different temperatures: diagnostic implications. Br J Vener Dis (1984) 1.59
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol (2007) 1.55
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol (2004) 1.53
Frequency of moles as a key to melanoma incidence? J Am Acad Dermatol (1986) 1.50
Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. Antimicrob Agents Chemother (1987) 1.47
A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol (1997) 1.46
Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res (1983) 1.45
Non-von Recklinghausen's neurofibromatosis resembling a giant pigmented nevus. J Am Acad Dermatol (1989) 1.44
Use of cyclosporin in psoriasis. Lancet (1990) 1.43
Activation of complement in psoriasis. Clin Exp Dermatol (1998) 1.39
The risk of sensibilization and contact urticaria upon topical application of fumaric acid derivatives. Dermatology (1994) 1.38
Neopterin, immune activation, and psoriasis. Lancet (1991) 1.38
Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol (1993) 1.35
Evaluation of the direct fluorescent antibody test for diagnosis of chlamydial infections. Eur J Clin Microbiol (1985) 1.35
High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol (1991) 1.30
Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol (1993) 1.28
Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol (1999) 1.25
Incidence of circulating antibodies reactive with basal cells of skin in drug reactions. Acta Derm Venereol (1974) 1.24
Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g. J Antimicrob Chemother (1984) 1.22
Direct immunofluorescent study of the skin on occurrence of complement in pemphigus. Br J Dermatol (1972) 1.20
Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers -- IL-12, IL-18 and IL-23. Exp Dermatol (2004) 1.19
A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol (1998) 1.16
Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. Eur J Clin Microbiol (1986) 1.16
Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol (1998) 1.13
Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res (1999) 1.13
Ascertainment of hand dermatitis using a symptom-based questionnaire; applicability in an industrial population. Contact Dermatitis (2000) 1.13
CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial. Br J Dermatol (2006) 1.10
Treponemicidal levels of amoxicillin in cerebrospinal fluid after oral administration. Sex Transm Dis (1984) 1.10
Frequency of allergic reactions to methyldibromoglutaronitrile (1,2-dibromo-2,4-dicyanobutane) in The Netherlands. Contact Dermatitis (1991) 1.10
Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol (2008) 1.08
Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods. Br J Dermatol (2009) 1.08
Solid-phase enzyme immunoassay for detection of Chlamydia trachomatis. Eur J Clin Microbiol (1985) 1.06
Sensitization to fragrance materials in Indonesian cosmetics. Contact Dermatitis (1990) 1.06
Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol (1990) 1.06
EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy (2011) 1.05
Causes, investigation and treatment of leg ulceration. Br J Dermatol (2003) 1.03
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol (2001) 1.03
Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis. Ann Rheum Dis (2004) 1.03
Review and expert opinion on prevention and treatment of infliximab-related infusion reactions. Br J Dermatol (2008) 1.02
Efficacy of low-dose cyclosporine in severe atopic skin disease. Arch Dermatol (1987) 1.02
Reduced frequency of nickel allergy upon oral nickel contact at an early age. Clin Exp Immunol (1991) 1.01
Dermal organization in scleroderma: the fast Fourier transform and the laser scatter method objectify fibrosis in nonlesional as well as lesional skin. Lab Invest (2000) 1.00
Mucopolysaccharides in suspensions of Treponema pallidum extracted from infected rabbit testes. Genitourin Med (1985) 1.00
Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol (2008) 1.00
Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines. J Invest Dermatol (2000) 1.00
Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxycillin (Augmentin). Genitourin Med (1986) 0.99
The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol (1999) 0.99
Different in situ distribution patterns of dendritic cells having Langerhans (T6+) and interdigitating (RFD1+) cell immunophenotype in psoriasis, atopic dermatitis, and other inflammatory dermatoses. J Invest Dermatol (1986) 0.98
Sexually communicable micro-organisms in human semen samples to be used for artificial insemination by donor. Genitourin Med (1987) 0.97
Contact allergy to benzydamine. Contact Dermatitis (1986) 0.97
Teledermatology applied following patient selection by general practitioners in daily practice improves efficiency and quality of care at lower cost. Br J Dermatol (2011) 0.97
Immunoglobulin-bearing lymphoid cells in primary syphilis. Quantitative and elution studies. Br J Vener Dis (1980) 0.96
Th1 lymphokine production profiles of nickel-specific CD4+T-lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol (1992) 0.96
Nickel-specific T lymphocyte clones derived from allergic nickel-contact dermatitis lesions in man: heterogeneity based on requirement of dendritic antigen-presenting cell subsets. Eur J Immunol (1987) 0.96
Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol (2004) 0.95
Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation. J Immunol (1994) 0.95
Pityriasis rosea (Gibert): abnormal distribution pattern of antigen presenting cells in situ. Acta Derm Venereol (1985) 0.95
Ultrastructural findings in progressive macular hypomelanosis indicate decreased melanin production. J Eur Acad Dermatol Venereol (2008) 0.95
Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin. Eur J Clin Microbiol (1986) 0.95
Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol (1996) 0.94
Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients. J Am Acad Dermatol (1995) 0.94
Prevalence of antibodies to Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in infertile women. Genitourin Med (1985) 0.93
Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp Dermatol (2005) 0.93
Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin. Arch Dermatol Res (1994) 0.93
Erythromelalgia and thrombocythemia: a causal relation. J Am Acad Dermatol (1990) 0.93
Idiopathic erythermalgia: a congenital disorder. J Am Acad Dermatol (1989) 0.93
Delayed hypersensitivity to scopolamine in transdermal therapeutic systems. J Am Acad Dermatol (1988) 0.92
Quantification and distribution of lymphocyte subsets and Langerhans cells in normal human oral mucosa and skin. J Oral Pathol Med (1989) 0.92
Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis. J Dermatolog Treat (2004) 0.91
Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. J Eur Acad Dermatol Venereol (2007) 0.91
Effect of early and late syphilis on central nervous system: cerebrospinal fluid changes and neurological deficit. Genitourin Med (1987) 0.91
Primary and secondary erythermalgia, a critical review. Neth J Med (1988) 0.91
Central nervous system involvement in early and late syphilis: the problem of asymptomatic neurosyphilis. J Neurol Sci (1988) 0.90
Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol (1998) 0.90
Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles. Clin Exp Allergy (2004) 0.90
Discoid lupus erythematosus-like skin changes in patients with autosomal recessive chronic granulomatous disease. Arch Dermatol (1990) 0.90
Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur J Immunol (1990) 0.89
Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored. Br J Dermatol (2009) 0.89
Analysis of effector and regulatory immune reactivity to nickel. Clin Exp Allergy (2004) 0.89